156 related articles for article (PubMed ID: 21968569)
1. Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing.
Zhou J; Belov L; Solomon MJ; Chan C; Clarke SJ; Christopherson RI
J Vis Exp; 2011 Sep; (55):. PubMed ID: 21968569
[TBL] [Abstract][Full Text] [Related]
2. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
Zhou J; Belov L; Huang PY; Shin JS; Solomon MJ; Chapuis PH; Bokey L; Chan C; Clarke C; Clarke SJ; Christopherson RI
J Immunol Methods; 2010 Apr; 355(1-2):40-51. PubMed ID: 20156443
[TBL] [Abstract][Full Text] [Related]
3. Multiplex detection of surface molecules on colorectal cancers.
Ellmark P; Belov L; Huang P; Lee CS; Solomon MJ; Morgan DK; Christopherson RI
Proteomics; 2006 Mar; 6(6):1791-802. PubMed ID: 16485257
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
5. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
6. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
7. Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays.
Belov L; Hallal S; Matic K; Zhou J; Wissmueller S; Ahmed N; Tanjil S; Mulligan SP; Best OG; Simpson RJ; Christopherson RI
Methods Mol Biol; 2017; 1619():263-301. PubMed ID: 28674892
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.
Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD
BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062
[TBL] [Abstract][Full Text] [Related]
11. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
12. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
[TBL] [Abstract][Full Text] [Related]
13. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
15. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
[TBL] [Abstract][Full Text] [Related]
16. Surface Antigen Profiling of Helicobacter pylori-Infected and -Uninfected Gastric Cancer Cells Using Antibody Microarray.
Sukri A; Hanafiah A; Kosai NR; Mohamed Taher M; Mohamed Rose I
Helicobacter; 2016 Oct; 21(5):417-27. PubMed ID: 26807555
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis.
Shi H; Hood KA; Hayes MT; Stubbs RS
J Proteomics; 2011 Dec; 75(2):339-51. PubMed ID: 21843667
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe.
Wang S; Li W; Yuan D; Song J; Fang J
Int J Nanomedicine; 2016; 11():235-47. PubMed ID: 26834472
[TBL] [Abstract][Full Text] [Related]
19. An extended antibody microarray for surface profiling metastatic melanoma.
Kaufman KL; Belov L; Huang P; Mactier S; Scolyer RA; Mann GJ; Christopherson RI
J Immunol Methods; 2010 Jun; 358(1-2):23-34. PubMed ID: 20363224
[TBL] [Abstract][Full Text] [Related]
20. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
